Clinical presentation of new onset refractory status epilepticus in children (the pSERG cohort)

Claudine Sculier1,2, Cristina Barcia Aguilar1,3, Nicolas Gaspard2,4

  • 1Division of Epilepsy and Clinical Neurophysiology, Department of Neurology, Boston Children's Hospital, Harvard Medical School, Boston, MA, USA.

Epilepsia
|June 6, 2021
PubMed

Insights

New onset refractory status epilepticus (NORSE) in children is often of unknown cause and associated with fever. Fever preceding seizures indicates prolonged episodes and poorer outcomes in pediatric patients.

Area of Science:

  • Pediatric Neurology
  • Epileptology
  • Critical Care Medicine

Background:

  • New Onset Refractory Status Epilepticus (NORSE) is a rare but severe neurological emergency in children.
  • Understanding the clinical profile and outcomes of pediatric NORSE is crucial for effective management.
  • The role of fever in the etiology and prognosis of NORSE requires further investigation.

Purpose of the Study:

  • To characterize the clinical presentation and outcomes of pediatric NORSE.
  • To investigate the association between fever onset and the characteristics of status epilepticus (SE).
  • To differentiate subgroups within NORSE based on fever timing and its impact on outcomes.

Main Methods:

  • Prospective enrollment of pediatric patients with refractory SE (RSE) into the pSERG cohort.
  • Classification of NORSE cases into "known etiology" and "unknown etiology."
  • Subgroup analysis of NORSE of unknown etiology based on fever occurrence relative to RSE onset (at onset, previous, or no fever).

Main Results:

  • 46 out of 279 RSE patients met NORSE criteria (16%); 87% were of unknown etiology.
  • Fever at SE onset (48%) was associated with younger age, shorter SE duration, and better recovery (89% baseline function).
  • Preceding fever (40%) correlated with prolonged SE, worse outcomes, and lower recovery rates (25% baseline function).

Conclusions:

  • Pediatric NORSE, particularly of unknown etiology, is frequently associated with fever.
  • Fever timing is a significant factor influencing SE duration and neurological outcomes in pediatric NORSE.
  • Fever occurring >24 hours before seizures may identify a subgroup with distinct clinical features and poorer prognosis, potentially overlapping with FIRES.
Abstract